Ryan Specialty (NYSE:RYAN – Get Free Report) is set to post its quarterly earnings results after the market closes on Thursday, November 2nd. Analysts expect Ryan Specialty to post earnings of $0.32 per share for the quarter. Investors that are interested in participating in the company’s conference call can do so using this link.
Ryan Specialty (NYSE:RYAN – Get Free Report) last issued its quarterly earnings results on Thursday, August 3rd. The company reported $0.45 earnings per share for the quarter, topping analysts’ consensus estimates of $0.42 by $0.03. Ryan Specialty had a return on equity of 39.86% and a net margin of 10.34%. The company had revenue of $585.10 million for the quarter, compared to analyst estimates of $575.80 million. During the same quarter in the prior year, the company posted $0.39 EPS. The business’s revenue for the quarter was up 19.1% compared to the same quarter last year. On average, analysts expect Ryan Specialty to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.
Ryan Specialty Trading Down 1.0 %
Shares of Ryan Specialty stock opened at $45.93 on Thursday. Ryan Specialty has a fifty-two week low of $32.13 and a fifty-two week high of $50.64. The firm has a market cap of $11.95 billion, a PE ratio of 76.55 and a beta of 0.43. The business’s fifty day moving average is $47.82 and its two-hundred day moving average is $44.71. The company has a quick ratio of 1.22, a current ratio of 1.22 and a debt-to-equity ratio of 2.06.
Analyst Upgrades and Downgrades
Get Our Latest Stock Analysis on RYAN
Insider Activity at Ryan Specialty
In related news, insider Lisa Jo Paschal-Alcorn sold 2,202 shares of the firm’s stock in a transaction that occurred on Monday, August 14th. The shares were sold at an average price of $45.00, for a total transaction of $99,090.00. Following the transaction, the insider now owns 46,422 shares in the company, valued at $2,088,990. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In other Ryan Specialty news, insider Lisa Jo Paschal-Alcorn sold 2,202 shares of Ryan Specialty stock in a transaction that occurred on Monday, August 14th. The shares were sold at an average price of $45.00, for a total value of $99,090.00. Following the transaction, the insider now owns 46,422 shares in the company, valued at $2,088,990. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, Director Nicholas Dominic Cortezi sold 4,283 shares of the firm’s stock in a transaction that occurred on Friday, August 18th. The stock was sold at an average price of $44.68, for a total transaction of $191,364.44. The disclosure for this sale can be found here. Insiders have sold 218,132 shares of company stock worth $9,687,125 over the last quarter. 54.51% of the stock is currently owned by company insiders.
Institutional Inflows and Outflows
Several institutional investors have recently bought and sold shares of the company. Vanguard Group Inc. increased its holdings in shares of Ryan Specialty by 5.7% during the 3rd quarter. Vanguard Group Inc. now owns 7,559,285 shares of the company’s stock worth $307,058,000 after purchasing an additional 405,000 shares during the period. BlackRock Inc. increased its stake in Ryan Specialty by 13.7% in the second quarter. BlackRock Inc. now owns 4,026,945 shares of the company’s stock valued at $180,770,000 after acquiring an additional 486,706 shares during the period. Morgan Stanley increased its stake in Ryan Specialty by 515.7% in the fourth quarter. Morgan Stanley now owns 2,467,647 shares of the company’s stock valued at $102,432,000 after acquiring an additional 2,066,855 shares during the period. Price T Rowe Associates Inc. MD increased its stake in Ryan Specialty by 35.2% in the second quarter. Price T Rowe Associates Inc. MD now owns 2,072,078 shares of the company’s stock valued at $81,205,000 after acquiring an additional 539,003 shares during the period. Finally, T. Rowe Price Investment Management Inc. increased its stake in Ryan Specialty by 16.5% in the fourth quarter. T. Rowe Price Investment Management Inc. now owns 1,805,914 shares of the company’s stock valued at $74,964,000 after acquiring an additional 256,292 shares during the period. Institutional investors own 34.09% of the company’s stock.
About Ryan Specialty
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
Featured Articles
- Five stocks we like better than Ryan Specialty
- How to Invest in Casino Stocks
- The top 3 stocks insiders are selling, but you shouldn’t
- Financial Services Stocks Investing
- Spirit AeroSystems Goes Airborne After Inking a Boeing Deal
- ETF Screener: Uses and Step-by-Step Guide
- Simon Property Group’s 7.2% Dividend Has Insiders Buying In Bulk
Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.
